Novus Biologicals™ DDAH2 Antibody Blocking Peptide

Catalog No.	Quantity
NBP158859E	100 μg

Catalog No. NBP158859E Supplier Novus Biologicals™ Supplier No. NBP158859PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide from human DDAH2. Source: Synthetic (Accession #: NP_039268) The DDAH2 Blocking Peptide is derived from Synthetic. The DDAH2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 23564
• Species: Human
• Accession Number: O95865
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: Lyophilized from sterile distilled water.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-58859. This Synthetic Peptide is Designed for Use in an Antibody Competition Assay with Its Corresponding Antibody. Use of This Product in Any Other Assay Has Not Yet Been Tested. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: DDAHII, dimethylargininase-2, dimethylarginine dimethylaminohydrolase 2G6a, dimethylarginine dimethylaminohydrolase II, EC 3.5.3.18, G6a, N(G), N(G)-dimethylarginine dimethylaminohydrolase 2, NG30, NG-dimethylarginine dimethylamino hydrolase homolog, S-phase protein
• Gene Symbol: DDAH2
• Molecular Weight (g/mol): 31kDa
• Product Type: DDAH2
• Quantity: 100 μg
• Regulatory Status: RUO - research use only
• Termination: Blocking Peptide fo th N terminal of protein